ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: TH-PO1044

Association between Use of Phosphate-Binders and the Risk of Infection-Related Mortality in Hemodialysis Patients: The Q-Cohort Study

Session Information

Category: Mineral Disease

  • 1201 Mineral Disease: Ca/Mg/PO4

Authors

  • Yamada, Shunsuke, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  • Tokumoto, Masanori, Department of Medicine, Fukuoka Dental College, Fukuoka, Japan
  • Taniguchi, Masatomo, Fukuoka Renal Clinic, Fukuoka, Japan
  • Hirakata, Hideki N., Fukuoka Renal Clinic, Fukuoka, Japan
  • Kitazono, Takanari, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  • Tsuruya, Kazuhiko, Kyushu University, Fukuoka, Japan
Background

Use of phosphate (P)-binders enables hemodialysis patients to take more protein, stay in a better nutritional status, and maintain serum P level in a recommended range. By contrast, dietary protein restriction often leads to protein-energy-malnutrition, which is closely related to the increased risk of infection-related deaths. However, it still remains unknown whether the risk of infection-related deaths is decreased in patients with P-binders compared with those without P-binders.

Methods

The present study was a prospective multicenter observational study consisting of 2926 hemodialysis patients registered to the Q-Cohort Study. The main exposure was use of P-binders and the main outcome was infection-related deaths. Patients’ information was collected only at baseline. Propensity score (PS) for P-binder use was created by multivariable logistic regression analysis. Multivariable-adjusted Cox proportional hazards models with or without PS-based approaches were used to estimate the risk of infection-related mortality.

Results

During the 3.9 years of median follow-up period, 106 patients died of infection. Patients with P-binders showed a higher body mass index and normalized protein catabolic rate and higher serum levels of creatinine and albumin compared with those without P-binders. Even after adjustment for confounding factors including serum levels of P, albumin, and creatinine, protein catabolic rate, and body mass index, the incidence of infection-relate deaths was significantly lower in patients with P-binders than those without P-binders; hazard ratio [95% confidence interval] for infection-related deaths was 0.63 [0.40–0.99]. The associations remained significant even after applying four different propensity score (PS) based adjustments; PS matching, PS stratification, PS covariate adjustment, and inverse probability weighting treatment.

Conclusion

Our results suggest that use of P-binders was significantly associated with a lower incidence of infection-related deaths in hemodialysis patients, even after accounting the nutritional factors and confounding by indication. Further studies are necessary to determine why P-binder users have the advantage of having a lower risk of infection-related deaths in hemodialysis patients.